Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.
In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome).
Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.
What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.
The Director, Pipeline & Portfolio Market Planning is accountable for shaping and driving Corcept’s product and portfolio strategies across clinical-stage programs. This leader will guide indication selection and sequencing, competitive landscape assessment, patient journey and treatment paradigm analysis, target product profile (TPP) development, product positioning, and long-range financial forecasting. The Director will serve as a key strategic partner to R&D, Commercial, and Executive Leadership, ensuring data-driven decisions that maximize the value and impact of Corcept’s portfolio.
Responsibilities:
- Drive and influence program-level strategy initiatives to define product vision, optimize lifecycle value, and drive business impact
- Provide physician, patient, and payer perspective in clinical strategy and new product planning
- Design, implement, and continuously refine competitive intelligence and market analysis frameworks that proactively inform program decision-making
- Independently lead integrated cross-functional teams, including Commercial, Medical, Development, and Research, to ensure alignment and strategic continuity across the product lifecycle
- Develop, maintain, and communicate robust long-range revenue forecasts and valuation models to support program planning and resource allocation
- Synthesize market research, competitive intelligence, and analytics into actionable insights to inform executive decision-making
- Own the development and management of target product profiles (TPPs) for pipeline products, working with R&D teams to influence and support decisions
- Lead asset assessments and contribute to business development diligence, guiding executive decision-making
- Oversee and execute ad hoc cross-portfolio workstreams, including global expansion initiatives in partnership with Emerging Markets team
- Model and promote Corcept’s key principles, collaborating effectively, embracing possibilities, following the data, and leading by doing, to build a culture of accountability, innovation, and trust
Preferred Skills, Qualifications and Technical Proficiencies:
- Proven ability to lead strategic planning initiatives across multiple therapeutic areas, integrating scientific, clinical, commercial, and regulatory perspectives
- Deep understanding of the drug development process, spanning early through late-stage programs, with experience translating clinical insights into commercial strategy
- Exceptional executive communication skills; adept at conveying insights and strategies to senior leadership through compelling storytelling
- Strong market research and analytical acumen with the ability to translate data into compelling strategic recommendations
- Skilled at operating effectively in a dynamic, matrixed environment, building alignment and influencing stakeholders across R&D, Commercial, Medical, Finance, and Executive functions
- Proven ability to rapidly synthesize information from multiple internal and external sources
- Occasional travel required for corporate and industry events
Preferred Education and Experience:
- Bachelor's degree required. Advanced degree preferred (MBA, MSc, PhD, PharmD)
- 8-10 years in product planning preferred, with relevant professional experience in new product planning, commercial planning, program management, corporate development and/or healthcare strategy consulting considered
- Experience within relevant therapeutic areas such as oncology, neurology and/or rare diseases preferred
- Prior experience working as part of or leading cross-functional drug development teams strongly preferred
The pay range that the Company reasonably expects to pay for this headquarters-based position is $238,900 - $281,100; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.
Applicants must be currently authorized to work in the United States on a full-time basis.
For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link.
Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.
Please visit our website at: https://www.corcept.com/
Corcept is an Equal Opportunity Employer
Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.
Similar Jobs
What We Do
Leading the field in the discovery of drugs that modulate the effects of cortisol. The adverse effects of excess cortisol have been Corcept’s focus since the company’s inception. Abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol.
